Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox  study

Acute Kidney Injury (AKI), induced by Checkpoint Inhibitors therapies (CPI-induced AKI), is an uncommon but severe Immune-Related Adverse Event (IRAE). The aim was to describe the epidemiology, risks factors, clinical, and laboratory characteristics of these renal adverse events (AEs) in a real-life cohort treatment.

Source: European Journal of Cancer - February 16, 2021 Category: Cancer & Oncology Authors: M. Espi, C. Teuma, E. Novel-Catin, D. Maillet, P.J. Souquet, S. Dalle, L. Koppe, D. Fouque Tags: Original Research Source Type: research